4 Drug Stocks Facing FDA Approval Decisions in July

Description:

According to Adam Feuerstein, " Four FDA drug approval decisions in July -- headlined by another weight-loss drug and a prescription fish oil pill with blockbuster potential -- will keep biotech investors busy in what is normally one of the sector's slower months." Read more here.

>>Also: Hot Biotech Stocks Traded by Hedge Funds

>>Also: 22 Biopharma Stocks With Breakout Potential in 2012

Most Viewed Portfolios

View All

Articles

5 Earnings Short-Squeeze Plays

08.20.14 | 12:09 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

Why to Buy These 5 Under-$10 Stocks ASAP

08.20.14 | 08:48 AM

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percenta...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter